Javascript must be enabled to continue!
USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis
View through CrossRef
Objective
Helicobacter pylori (Hp) is a major risk factor for gastric cancer (GC). Hp promotes DNA damage and proteasomal degradation of p53, the guardian of genome stability. Hp reduces the expression of the transcription factor USF1 shown to stabilise p53 in response to genotoxic stress. We investigated whether Hp-mediated USF1 deregulation impacts p53-response and consequently genetic instability. We also explored in vivo the role of USF1 in gastric carcinogenesis.
Design
Human gastric epithelial cell lines were infected with Hp7.13, exposed or not to a DNA-damaging agent camptothecin (CPT), to mimic a genetic instability context. We quantified the expression of USF1, p53 and their target genes, we determined their subcellular localisation by immunofluorescence and examined USF1/p53 interaction. Usf1
-/- and INS-GAS mice were used to strengthen the findings in vivo and patient data examined for clinical relevance.
Results
In vivo we revealed the dominant role of USF1 in protecting gastric cells against Hp-induced carcinogenesis and its impact on p53 levels. In vitro, Hp delocalises USF1 into foci close to cell membranes. Hp prevents USF1/p53 nuclear built up and relocates these complexes in the cytoplasm, thereby impairing their transcriptional function. Hp also inhibits CPT-induced USF1/p53 nuclear complexes, exacerbating CPT-dependent DNA damaging effects.
Conclusion
Our data reveal that the depletion of USF1 and its de-localisation in the vicinity of cell membranes are essential events associated to the genotoxic activity of Hp infection, thus promoting gastric carcinogenesis. These findings are also of clinical relevance, supporting USF1 expression as a potential marker of GC susceptibility.
Title: USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis
Description:
Objective
Helicobacter pylori (Hp) is a major risk factor for gastric cancer (GC).
Hp promotes DNA damage and proteasomal degradation of p53, the guardian of genome stability.
Hp reduces the expression of the transcription factor USF1 shown to stabilise p53 in response to genotoxic stress.
We investigated whether Hp-mediated USF1 deregulation impacts p53-response and consequently genetic instability.
We also explored in vivo the role of USF1 in gastric carcinogenesis.
Design
Human gastric epithelial cell lines were infected with Hp7.
13, exposed or not to a DNA-damaging agent camptothecin (CPT), to mimic a genetic instability context.
We quantified the expression of USF1, p53 and their target genes, we determined their subcellular localisation by immunofluorescence and examined USF1/p53 interaction.
Usf1
-/- and INS-GAS mice were used to strengthen the findings in vivo and patient data examined for clinical relevance.
Results
In vivo we revealed the dominant role of USF1 in protecting gastric cells against Hp-induced carcinogenesis and its impact on p53 levels.
In vitro, Hp delocalises USF1 into foci close to cell membranes.
Hp prevents USF1/p53 nuclear built up and relocates these complexes in the cytoplasm, thereby impairing their transcriptional function.
Hp also inhibits CPT-induced USF1/p53 nuclear complexes, exacerbating CPT-dependent DNA damaging effects.
Conclusion
Our data reveal that the depletion of USF1 and its de-localisation in the vicinity of cell membranes are essential events associated to the genotoxic activity of Hp infection, thus promoting gastric carcinogenesis.
These findings are also of clinical relevance, supporting USF1 expression as a potential marker of GC susceptibility.
Related Results
Dérégulation du facteur de transcription USF1 et réponse génotoxique de l'hôte à l'infection par Helicobacter pylori et autres Helicobacters
Dérégulation du facteur de transcription USF1 et réponse génotoxique de l'hôte à l'infection par Helicobacter pylori et autres Helicobacters
Helicobacter pylori (H. pylori) est une bactérie pathogène infectant 50% de la population mondiale. Il s'agit du facteur de risque majeur pour le cancer gastrique. H. pylori induit...
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract
The tumor suppressor p53 is mutated in more than 50% of all cancers. The transcriptional activity of p53 depends on localization to the nucleus and formatio...
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
Helicobacter pylori and gastric cancer
Helicobacter pylori and gastric cancer
Introduction: According to GLOBOCAN estimates for 2018, gastric cancer was the fifth most common cancer and the third most common cause of death from malignant diseases in the worl...
THE CLINICAL CHARACTERISTICS, ENDOSCOPIC FINDINGS AND THE EFFICACY OF THE BISMUTH-CONTAINING QUADRUPLE REGIMEN INTREATMENT OF PATIENTS WITH HELICOBACTER PYLORIGASTRODUODENAL INFLAMMATORY AND ULCER AT CAN THO HOSPITAL OF UNIVERSITY OF MEDICINE AND PHARMACY
THE CLINICAL CHARACTERISTICS, ENDOSCOPIC FINDINGS AND THE EFFICACY OF THE BISMUTH-CONTAINING QUADRUPLE REGIMEN INTREATMENT OF PATIENTS WITH HELICOBACTER PYLORIGASTRODUODENAL INFLAMMATORY AND ULCER AT CAN THO HOSPITAL OF UNIVERSITY OF MEDICINE AND PHARMACY
Background: Helicobacter pylori causes inflammation of the gastric mucosa and is associated with many upper gastrointestinal diseases, including chronic gastritis, peptic ulcer dis...
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Abstract
Introduction: Infection with Helicobacter pylori is one of the most frequent chronic bacterial illnesses in humans, infecting more than half of the world's populat...
<i>Helicobacter pylori–Plasmodium falciparum</i> co-infection in adults in Idah, Nigeria: Prevalence, risk factors, and molecular confirmation of <i>H. pylori</i>
<i>Helicobacter pylori–Plasmodium falciparum</i> co-infection in adults in Idah, Nigeria: Prevalence, risk factors, and molecular confirmation of <i>H. pylori</i>
Background: Co-infection with Helicobacter pylori and Plasmodium falciparum represents an important public health concern in sub-Saharan Africa, where both infections are associate...

